Umbilical Cord Mesenchymal Stem Cell‐derived Exosomes Promote Axon Regeneration During Optic Nerve Injury Through Microrna‐dependent Mtorc1 Signalling
Xuan Sang,Lei Tang,Liang Zhao,Nana Xu,Feng Liu,Yuhui Shen,Wei,Yaqi Cheng,Wanjing Huang,Yurun Liu,Yaru Su,Chao Xu,Yongsheng Li,Zhichong Wang,Sheng Liu
DOI: https://doi.org/10.1002/ctm2.1319
IF: 8.554
2023-01-01
Clinical and Translational Medicine
Abstract:Dear Editor, Treatment for optic nerve (ON) injury remains a challenge worldwide. As essential paracrine signals of mesenchymal stem cells (MSCs), exosomes (exos) show source cell-like biological functions, which have recently been suggested to promote the functional recovery of central neurons.1–4 Reportedly, MSC-exos transfer active components, especially microRNAs (miRNAs), to facilitate intercellular communication, thereby exerting tissue regenerative effects.5–8 However, the effect of exos derived from umbilical cord MSCs (HuMSC-exos) and the underlying mechanisms in ON injury remain unclear. Here, we intended to explore whether HuMSC-exos have a neuroregenerative effect and the molecular mechanisms by which exosomal miRNAs play a role in this process. Exos were isolated from HuMSCs (Figure S1A–C) and purified by ultracentrifugation. Purified HuMSC-exos were identified by positive expression of their specific surface markers (CD9, CD63 and TSG101) by Western blotting (Figure S2A–E). They displayed typical exosomal features, including morphology and size, as detected by transmission electron microscopy (Figure S2F). Nanoparticle tracking analysis revealed that purified HuMSC-exos were relatively homogeneous particles, and the particle concentration in the distribution range of 30–200 nm was approximately 93.3% (Figure S2G). In the ON crush (ONC) model, HuMSC-exos promoted the survival of 30% of the retinal ganglion cells (RGCs) (Figure 1A,B), rescued 60% of the RGCs from apoptosis (Figure 1C,D), increased retinal nerve fibre layer thickness (Figure 1E–G) and promoted axon regeneration (Figure 1H–J) at 21 days after ONC. In addition, pattern electroretinography showed thatHuMSC-exos efficiently recovered the loss of RGC function after ONC (Figure 2A–C). Intravitreal injection ofHuMSC-exos rarely caused retinal detachment, and no other side effects were